{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:45:55Z","timestamp":1757540755722,"version":"3.37.3"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56 AI118361","R01 AI063200","K24 065298","K08 AI106420)"],"award-info":[{"award-number":["R56 AI118361","R01 AI063200","K24 065298","K08 AI106420)"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We evaluated the relationship between response to efflux pump inhibition in fluoroquinolone-resistant Mycobacterium tuberculosis (Mtb) isolates and differences in gene expression and expression quantitative trait loci (eQTL).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We determined ofloxacin minimum inhibitory concentration (MIC) for ofloxacin-resistant and -susceptible Mtb isolates without and with the efflux pump inhibitor verapamil. We performed RNA sequencing (RNA-seq), whole genome sequencing (WGS), and eQTL analysis, focusing on efflux pump, transport, and secretion-associated genes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 42 ofloxacin-resistant Mtb isolates, 27 had adequate WGS coverage and acceptable RNA-seq quality. Of these 27, 7 had &amp;gt;2-fold reduction in ofloxacin MIC with verapamil; 6 had 2-fold reduction, and 14 had &amp;lt;2-fold reduction. Five genes (including Rv0191) had significantly increased expression in the MIC fold change &amp;gt;2 compared to &amp;lt;2 groups. Among regulated genes, 31 eQTLs (without ofloxacin) and 35 eQTLs (with ofloxacin) had significant allele frequency differences between MIC fold change &amp;gt;2 and &amp;lt;2 groups. Of these, Rv1410c, Rv2459, and Rv3756c (without ofloxacin) and Rv0191 and Rv3756c (with ofloxacin) have previously been associated with antituberculosis drug resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this first reported eQTL analysis in Mtb, Rv0191 had increased gene expression and significance in eQTL analysis, making it a candidate for functional evaluation of efflux-mediated fluoroquinolone resistance in Mtb.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiad112","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T16:01:00Z","timestamp":1682006460000},"page":"469-478","source":"Crossref","is-referenced-by-count":4,"title":["<i>Mycobacterium tuberculosis<\/i> Gene Expression Associated With Fluoroquinolone Resistance and Efflux Pump Inhibition"],"prefix":"10.1093","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-9796","authenticated-orcid":false,"given":"Yuri F","family":"van der Heijden","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine , Vanderbilt University School of Medicine, Nashville, Tennessee , USA"},{"name":"Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine , Nashville, Tennessee , USA"},{"name":"The Aurum Institute , Johannesburg , South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9533-8239","authenticated-orcid":false,"given":"Fernanda","family":"Maruri","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine , Vanderbilt University School of Medicine, Nashville, Tennessee , USA"},{"name":"Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine , Nashville, Tennessee , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amondrea","family":"Blackman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine , Vanderbilt University School of Medicine, Nashville, Tennessee , USA"},{"name":"Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine , Nashville, Tennessee , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Morrison","sequence":"additional","affiliation":[{"name":"Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of New Mexico , Albuquerque, New Mexico , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R","family":"Sterling","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine , Vanderbilt University School of Medicine, Nashville, Tennessee , USA"},{"name":"Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine , Nashville, Tennessee , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"2023081611072850400_jiad112-B1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2471\/BLT.15.158998","article-title":"Antimicrobial resistance: a priority for global health action","volume":"93","author":"Chioro","year":"2015","journal-title":"Bull World Health Organ"},{"year":"2013","author":"Centers for Disease Control and Prevention (CDC)","key":"2023081611072850400_jiad112-B2"},{"volume-title":"Global tuberculosis report","year":"2021","author":"World Health Organization (WHO)","key":"2023081611072850400_jiad112-B3"},{"key":"2023081611072850400_jiad112-B4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1469-0691.2011.03551.x","article-title":"The ins and outs of Mycobacterium tuberculosis drug susceptibility testing","volume":"17","author":"Bottger","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2023081611072850400_jiad112-B5","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/AAC.05546-11","article-title":"The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance","volume":"56","author":"Schmalstieg","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2023081611072850400_jiad112-B6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1164\/rccm.201011-1924OC","article-title":"Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux","volume":"184","author":"Louw","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2023081611072850400_jiad112-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2011.00831.x","article-title":"Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis","volume":"63","author":"da Silva","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2023081611072850400_jiad112-B8","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","article-title":"Four-month rifapentine regimens with or without moxifloxacin for tuberculosis","volume":"384","author":"Dorman","year":"2021","journal-title":"N Engl J Med"},{"year":"2021","author":"World Health Organization (WHO)","key":"2023081611072850400_jiad112-B9"},{"key":"2023081611072850400_jiad112-B10","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/cid\/ciaa496","article-title":"Resistance-conferring mutations on whole-genome sequencing of fluoroquinolone-resistant and -susceptible Mycobacterium tuberculosis isolates: a proposed threshold for identifying resistance","volume":"72","author":"Maruri","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023081611072850400_jiad112-B11","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/jac\/dkw168","article-title":"A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis","volume":"71","author":"Eilertson","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2023081611072850400_jiad112-B12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jac\/dkaa507","article-title":"Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis","volume":"76","author":"Blackman","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2023081611072850400_jiad112-B13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/rccm.201304-0650OC","article-title":"Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor","volume":"188","author":"Gupta","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2023081611072850400_jiad112-B14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41564-020-00810-x","article-title":"Transcriptional regulator-induced phenotype screen reveals drug potentiators in Mycobacterium tuberculosis","volume":"6","author":"Ma","year":"2021","journal-title":"Nat Microbiol"},{"key":"2023081611072850400_jiad112-B15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"2023081611072850400_jiad112-B16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygeno.2014.03.006","article-title":"Multi-perspective quality control of Illumina exome sequencing data using QC3","volume":"103","author":"Guo","year":"2014","journal-title":"Genomics"},{"key":"2023081611072850400_jiad112-B17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2023081611072850400_jiad112-B18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"2023081611072850400_jiad112-B19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2023081611072850400_jiad112-B20","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2023081611072850400_jiad112-B21","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/ncomms5812","article-title":"A robust SNP barcode for typing Mycobacterium tuberculosis complex strains","volume":"5","author":"Coll","year":"2014","journal-title":"Nat Commun"},{"key":"2023081611072850400_jiad112-B22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"Edger: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2023081611072850400_jiad112-B23","doi-asserted-by":"crossref","first-page":"20120362","DOI":"10.1098\/rstb.2012.0362","article-title":"Expression quantitative trait loci: present and future","volume":"368","author":"Nica","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2023081611072850400_jiad112-B24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/bioinformatics\/bts163","article-title":"Matrix eQTL: ultra fast eQTL analysis via large matrix operations","volume":"28","author":"Shabalin","year":"2012","journal-title":"Bioinformatics"},{"key":"2023081611072850400_jiad112-B25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tube.2010.09.006","article-title":"The MycoBrowser portal: a comprehensive and manually annotated resource for mycobacterial genomes","volume":"91","author":"Kapopoulou","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"2023081611072850400_jiad112-B26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fmicb.2017.00711","article-title":"Interplay between mutations and efflux in drug resistant clinical isolates of Mycobacterium tuberculosis","volume":"8","author":"Machado","year":"2017","journal-title":"Front Microbiol"},{"key":"2023081611072850400_jiad112-B27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.05708-11","article-title":"SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis","volume":"56","author":"Tahlan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2023081611072850400_jiad112-B28","doi-asserted-by":"crossref","first-page":"e00940-17","DOI":"10.1128\/AAC.00940-17","article-title":"Identification of novel efflux proteins Rv0191, Rv3756c, Rv3008, and Rv1667c involved in pyrazinamide resistance in Mycobacterium tuberculosis","volume":"61","author":"Zhang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2023081611072850400_jiad112-B29","doi-asserted-by":"crossref","first-page":"974","DOI":"10.5588\/ijtld.21.0117","article-title":"Efflux pump gene expression study using RNA-seq in multidrug-resistant TB","volume":"25","author":"Lee","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2023081611072850400_jiad112-B30","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ng.2747","article-title":"Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis","volume":"45","author":"Farhat","year":"2013","journal-title":"Nat Genet"},{"key":"2023081611072850400_jiad112-B31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tube.2011.08.002","article-title":"PPE_MPTR genes are differentially expressed by Mycobacterium tuberculosis in vivo","volume":"91","author":"Soldini","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"2023081611072850400_jiad112-B32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1126\/science.aav5912","article-title":"PE\/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"key":"2023081611072850400_jiad112-B33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12931-020-01612-9","article-title":"Gene expression pattern analysis using dual-color RT-MLPA and integrative genome-wide association studies of eQTL for tuberculosis susceptibility","volume":"22","author":"Ai","year":"2021","journal-title":"Respir Res"},{"key":"2023081611072850400_jiad112-B34","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1073\/pnas.1115761109","article-title":"Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection","volume":"109","author":"Barreiro","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023081611072850400_jiad112-B35","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/AAC.00550-09","article-title":"Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth","volume":"53","author":"Ram\u00f3n-Garc\u00eda","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2023081611072850400_jiad112-B36","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/jac\/dky091","article-title":"Intramacrophage Mycobacterium tuberculosis efflux pump gene regulation after rifampicin and verapamil exposure","volume":"73","author":"Canezin","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2023081611072850400_jiad112-B37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.diagmicrobio.2013.02.033","article-title":"Expression analysis of efflux pump genes among drug-susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates and reference strains","volume":"76","author":"Calgin","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2023081611072850400_jiad112-B38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/jac\/dkp096","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance","volume":"63","author":"Devasia","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"2023081611072850400_jiad112-B39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5588\/ijtld.14.0814","article-title":"Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment","volume":"19","author":"Farhat","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"year":"2018","author":"World Health Organization","key":"2023081611072850400_jiad112-B40"},{"key":"2023081611072850400_jiad112-B41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1128\/AAC.04019-14","article-title":"Verapamil increases the bactericidal activity of bedaquiline against Mycobacterium tuberculosis in a mouse model","volume":"59","author":"Gupta","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2023081611072850400_jiad112-B42","doi-asserted-by":"crossref","first-page":"e02107-17","DOI":"10.1128\/AAC.02107-17","article-title":"Verapamil targets membrane energetics in Mycobacterium tuberculosis","volume":"62:","author":"Chen","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad112\/50188649\/jiad112.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/4\/469\/51115536\/jiad112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/4\/469\/51115536\/jiad112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:07:57Z","timestamp":1692184077000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/4\/469\/7133616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,20]]},"published-print":{"date-parts":[[2023,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad112","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2023,8,15]]},"published":{"date-parts":[[2023,4,20]]}}}